Topic Hub
27 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 27 of 27 clinical reviews.
Can you take rapamycin (sirolimus) with acetaminophen? A clinician-reviewed guide covering CYP metabolism overlap, hepatotoxicity risk, monitoring protocols, and dose-adjustment strategies.
Read clinical reviewA detailed clinical review of the rapamycin (sirolimus) and apixaban drug interaction, covering CYP3A4/P-gp mechanisms, bleeding risk, monitoring protocols, and dose-adjustment guidance.
Read clinical reviewA clinician-level review of the pharmacokinetic and pharmacodynamic interaction between sirolimus (rapamycin) and benzodiazepines, covering CYP3A4/P-gp mechanisms, severity classification, monitoring protocols, dose-adjustment strategies, and patient counseling.
Read clinical reviewClinical review of the rapamycin (sirolimus) and bupropion drug interaction, covering CYP enzyme mechanisms, severity rating, dose adjustments, monitoring parameters, and patient counseling.
Read clinical reviewClinical guide to the rapamycin (sirolimus) and clopidogrel drug interaction, covering CYP3A4 competition, P-glycoprotein overlap, severity grading, dose adjustment, and monitoring protocols.
Read clinical reviewCan you take rapamycin (sirolimus) with diphenhydramine? A physician-reviewed guide covering CYP3A4 metabolism, CNS and anticholinergic overlap, monitoring parameters, and dose-adjustment strategies.
Read clinical reviewA physician-reviewed guide to the pharmacokinetic and pharmacodynamic interactions between rapamycin (sirolimus) and estradiol HRT, including CYP3A4/P-gp mechanisms, VTE risk overlap, monitoring protocols, and dose-adjustment strategies.
Read clinical reviewClinical review of the rapamycin (sirolimus) and finasteride drug interaction, covering CYP3A4 metabolism, androgen pathway effects, monitoring parameters, and dose-adjustment guidance.
Read clinical reviewA detailed clinical review of the sirolimus, gabapentin drug interaction: mechanism, severity, monitoring parameters, dose-adjustment guidance, and patient counseling based on FDA labels and primary literature.
Read clinical reviewA physician-reviewed guide to the CYP3A4-based drug interaction between sirolimus (rapamycin) and hormonal contraceptives, covering mechanism, severity, monitoring, dose adjustment, and patient counseling.
Read clinical reviewClinical guide to the rapamycin (sirolimus) and levothyroxine drug interaction, including mechanism, severity, monitoring protocols, dose adjustments, and patient counseling from the HealthRX.com medical team.
Read clinical reviewCan you take rapamycin (sirolimus) with metformin? A physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction, monitoring protocols, dose adjustments, and real-world clinical evidence.
Read clinical reviewClinical guide to the rapamycin (sirolimus) and NSAID interaction. Covers renal risk, GI bleeding, pharmacokinetic overlap, monitoring labs, and dose-adjustment strategies.
Read clinical reviewA clinician-level review of the sirolimus, opioid drug interaction, covering CYP3A4/P-gp mechanisms, severity ratings, monitoring parameters, dose-adjustment guidance, and patient counseling for oxycodone, hydrocodone, and tramadol.
Read clinical reviewClinical guide to the rapamycin (sirolimus) and PPI interaction. Covers CYP3A4/P-gp mechanisms, omeprazole vs. pantoprazole differences, monitoring, and dose adjustment.
Read clinical reviewA detailed clinical review of the pharmacokinetic and pharmacodynamic interaction between sirolimus (rapamycin) and pregabalin, covering mechanism, severity, monitoring, dose adjustment, and patient counseling.
Read clinical reviewA clinician-level review of the pharmacokinetic and pharmacodynamic interaction between sirolimus (rapamycin) and progesterone HRT, including CYP3A4/P-gp mechanisms, monitoring protocols, and dose-adjustment guidance.
Read clinical reviewClinical guide to the sirolimus-rivaroxaban drug interaction. Covers CYP3A4 and P-glycoprotein overlap, bleeding and toxicity risks, monitoring protocols, and dose-adjustment strategies reviewed by physicians.
Read clinical reviewA clinician-reviewed guide to the drug interaction between rapamycin (sirolimus) and rosuvastatin, covering pharmacokinetic mechanisms, muscle toxicity risk, monitoring protocols, and dose adjustments.
Read clinical reviewA clinical review of the rapamycin (sirolimus) and sildenafil drug interaction, covering CYP3A4 metabolism, blood level changes, dose adjustment, monitoring, and safety considerations.
Read clinical reviewClinical guide to the sirolimus-simvastatin drug interaction. Covers CYP3A4 mechanism, rhabdomyolysis risk, dose limits, monitoring protocols, and statin alternatives for patients on rapamycin.
Read clinical reviewClinical guide to combining sirolimus with SNRIs like venlafaxine or duloxetine. Covers CYP3A4 metabolism, bleeding risk, blood pressure overlap, monitoring protocols, and dose adjustments.
Read clinical reviewA detailed clinical guide to the rapamycin (sirolimus) and tadalafil drug interaction, covering CYP3A4 metabolism, dose adjustments, monitoring parameters, and patient counseling.
Read clinical reviewA clinician-reviewed guide to the pharmacokinetic and pharmacodynamic interactions between rapamycin (sirolimus) and testosterone, including CYP3A4 overlap, polycythemia risk, lipid effects, and monitoring protocols.
Read clinical reviewA detailed clinical review of the pharmacokinetic and pharmacodynamic interaction between sirolimus (rapamycin) and trazodone, covering CYP3A4/P-gp mechanisms, severity ratings, monitoring parameters, dose-adjustment strategies, and patient counseling points.
Read clinical reviewA physician-reviewed deep dive into the sirolimus, warfarin drug interaction: CYP3A4/P-gp mechanism, INR monitoring, dose adjustment, and patient counseling backed by primary literature and FDA labeling.
Read clinical reviewCan you take rapamycin (sirolimus) with zolpidem? A physician-reviewed guide covering the CYP3A4 interaction mechanism, severity rating, dose adjustment, monitoring, and patient counseling.
Read clinical review